Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes

Virus Research

Volumn 176, Issue 1-2, 2013, Pages 280-284

  Beasley, David W C ^a   Morin, Merribeth ^b,e   Lamb, Ashley R ^a   Hayman, Edward ^b   Watts, Douglas M ^a,d   Lee, Cynthia K ^b,e   Trent, Dennis W ^b,f   Monath, Thomas P ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Xcellerex Inc   (United States)

^c Kleiner Perkins Caufield & Byers   (United States)

^d UNIVERSITY OF TEXAS AT EL PASO   (United States)

^e PATH Malaria Vaccine Initiative   (United States)

^f UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Vaccine; Vero cells; Yellow fever virus

Indexed keywords

AMINO ACID; ARGININE; ENVELOPE PROTEIN; ISOLEUCINE; LYSINE; METHIONINE; NONSTRUCTURAL PROTEIN 4B; STRUCTURAL PROTEIN; YELLOW FEVER VACCINE;

ADAPTATION; AMINO ACID SEQUENCE; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; HUMAN; MOSQUITO; MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VERO CELL; YELLOW FEVER FLAVIVIRUS;

FLAVIVIRUS; YELLOW FEVER VIRUS;

EID: 84881377055     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.04.003     Document Type: Article

References (23)

1. Blaney J.E., Johnson D.H., Firestone C.Y., Hanson C.T., Murphy B.R., Whitehead S.S. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in Vero cells or human liver cells and attenuated in mice. Journal of Virology 2001, 75(20):9731-9740.
2. Blaney J.E., Johnson D.H., Manipon G.G., Firestone C.Y., Hanson C.T., Murphy B.R., Whitehead S.S. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells. Virology 2002, 300(1):125-139.
3. Blaney J.E., Manipon G.G., Firestone C.Y., Johnson D.H., Hanson C.T., Murphy B.R., Whitehead S.S. Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells. Vaccine 2003, 21(27-30):4317-4327.
4. Clyde K., Barrera J., Harris E. The capsid-coding region hairpin element (cHP) is a critical determinant of dengue virus and West Nile virus RNA synthesis. Virology 2008, 379(2):314-323.
5. Clyde K., Harris E. RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. Journal of Virology 2006, 80(5):2170-2182.
6. Daffis S., Kontermann R.E., Korimbocus J., Zeller H., Klenk H.D., Ter Meulen J. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants. Virology 2005, 337(2):262-272.
7. dos Santos C.N., Post P.R., Carvalho R., Ferreira I.I., Rice C.M., Galler R. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. Virus Research 1995, 35(1):35-41.
8. Galler R., Post P.R., Santos C.N., Ferreira I.I. Genetic variability among yellow fever virus 17D substrains. Vaccine 1998, 16(9-10):1024-1028.
9. Julander J.G., Trent D.W., Monath T.P. Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model. Vaccine 2011, 29(35):6008-6016.
10. Monath T.P., Cetron M.S., Teuwen D.E. Yellow fever vaccine. Vaccines 2008, Saunders/Elsevier, Philadelphia, PA. fifth ed. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
11. Monath T.P., Fowler E., Johnson C.T., Balser J., Morin M.J., Sisti M., Trent D.W. An inactivated cell-culture vaccine against yellow fever. New England Journal of Medicine 2011, 364(14):1326-1333.
12. Monath T.P., Lee C.K., Julander J.G., Brown A., Beasley D.W., Watts D.M., Hayman E., Guertin P., Makowiecki J., Crowell J., Levesque P., Bowick G.C., Morin M., Fowler E., Trent D.W. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine 2010, 28(22):3827-3840.
13. Pletnev A.G., Putnak R., Speicher J., Wagar E.J., Vaughn D.W. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(5):3036-3041.
14. Post P.R., Santos C.N., Carvalho R., Cruz A.C., Rice C.M., Galler R. Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains. Virology 1992, 188(1):160-167.
15. Qu L., McMullan L.K., Rice C.M. Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity. Journal of Virology 2001, 75(22):10651-10662.
16. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., Strauss J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 1985, 229(4715):726-733.
17. Rouha H., Hoenninger V.M., Thurner C., Mandl C.W. Mutational analysis of three predicted 5'-proximal stem-loop structures in the genome of tick-borne encephalitis virus indicates different roles in RNA replication and translation. Virology 2011, 417(1):79-86.
18. Ryman K.D., Ledger T.N., Weir R.C., Schlesinger J.J., Barrett A.D. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. Journal of General Virology 1997, 78(Pt 6):1353-1356.
19. Sampath A., Padmanabhan R. Molecular targets for flavivirus drug discovery. Antiviral Research 2009, 81(1):6-15.
20. Stock N.K., Boschetti N., Herzog C., Appelhans M.S., Niedrig M. The phylogeny of yellow fever virus 17D vaccines. Vaccine 2012, 30(6):989-994.
21. Tang W.F., Eshita Y., Tadano M., Morita K., Makino Y. Molecular basis for adaptation of a chimeric dengue type-4/Japanese encephalitis virus to Vero cells. Microbiology and Immunology 2005, 49(3):285-294.
22. Xie H., Cass A.R., Barrett A.D. Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations. Virus Research 1998, 55(1):93-99.
23. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research 2003, 31(13):3406-3415.